Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Leukemia Research
|
May 4, 2004
Allelic loss during progression of follicular lymphoma
Seisho Takeuchi, Sven de Vos, Naoko Takeuchi, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures
Daruka Mahadevan, Catherine Spier, Kimiko Della Croce, et al.
Human Pathology
|
July 21, 2007
Metallographic in situ hybridization
Richard D Powell, James D Pettay, William C Powell, et al.
Diagnostic Pathology
|
July 23, 2014
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas
Lisa M Rimsza, William A Day, Sarah McGinn, et al.
Blood
|
April 20, 2002
Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients
James R Berenson, John J Crowley, Thomas M Grogan, et al.
Methods (San Diego, Calif.)
|
July 13, 2010
Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models
Hiroaki Nitta, Wenjun Zhang, Brian D Kelly, et al.
Blood
|
August 6, 2005
A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis
Margaret E Tome, David B F Johnson, Lisa M Rimsza, et al.
Cancer
|
May 10, 2013
Mutation-specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas
Frank A Sinicrope, Thomas C Smyrk, David Tougeron, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 17, 2011
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas
Akihiko Yoshida, Koji Tsuta, Hiroaki Nitta, et al.
Transplantation
|
July 23, 2008
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder
Lode J Swinnen, Michael LeBlanc, Thomas M Grogan, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Leukemia Research
|
May 4, 2004
Allelic loss during progression of follicular lymphoma
Seisho Takeuchi, Sven de Vos, Naoko Takeuchi, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures
Daruka Mahadevan, Catherine Spier, Kimiko Della Croce, et al.
Human Pathology
|
July 21, 2007
Metallographic in situ hybridization
Richard D Powell, James D Pettay, William C Powell, et al.
Diagnostic Pathology
|
July 23, 2014
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas
Lisa M Rimsza, William A Day, Sarah McGinn, et al.
Blood
|
April 20, 2002
Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients
James R Berenson, John J Crowley, Thomas M Grogan, et al.
Methods (San Diego, Calif.)
|
July 13, 2010
Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models
Hiroaki Nitta, Wenjun Zhang, Brian D Kelly, et al.
Blood
|
August 6, 2005
A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis
Margaret E Tome, David B F Johnson, Lisa M Rimsza, et al.
Cancer
|
May 10, 2013
Mutation-specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas
Frank A Sinicrope, Thomas C Smyrk, David Tougeron, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 17, 2011
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas
Akihiko Yoshida, Koji Tsuta, Hiroaki Nitta, et al.
Transplantation
|
July 23, 2008
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder
Lode J Swinnen, Michael LeBlanc, Thomas M Grogan, et al.
Page
of 6